Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from egyptian villagers

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 6, 1999, Pages 932-935

  Ismail, Magdi ^a   Botros, Sanaa ^b   Metwally, Aiesha ^b   William, Samia ^b   Farghally, Adel ^a   Tao, Liang Fang ^c   Day, Tim A ^d   Bennett, James L ^d  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG SENSITIVITY; EGYPT; HUMAN; IMMUNE SYSTEM; NONHUMAN; PARASITE ISOLATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0033033093     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.932     Document Type: Article

References (12)

1. Andrews P, Thomas H, 1983. Praziquantel. Med Res Rev 3: 147-200.
2. Michelson MK, Axxis FA, Gamil FM, Spencer, HC, 1993. Recent trends in the prevlaence and distribution of schistosomiasis in the Nile delta region. Am J Trop Med Hyg 49: 76-87.
3. Homeida MA, Fenwick A, Dafalla AA, Nash T, Bennett JL. 1988. The effect of antischistosomal chemotherapy of the prevalence of Symmers' fibrosis in Sudanese villagers. Lancet 2: 437-440.
4. Fallon PG, Doenhoff MJ, 1994. Drug-resistant schistosomiasis: resistance to praziquantel and oxaminquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-89.
5. Fallon PG, Tao FF, Ismail MM, Bennett JL 1996. Schistosome resistance to praziquantel: fact or artifact? Parasitol Today 12: 316-318.
6. Brindley PJ, Strand M, Norden A, Sher A, 1989. A role of host antibody in the chemotherapeutic action of praziquantel against S. mansoni. Mol Biochem Parasitol 34: 99-108.
7. Sabah AA, Fletcher C, Webbe G, Doenhoff, MJ, 1986. Schistosoma mansoni: chemotherapy of infections of different ages. Parasitology 61: 294-303.
8. Metwally A, Bennett JL, Botros S, Ebeid F, Attar GDM, 1995. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol Res 31: 53-59.
9. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL, 1996. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 55: 212-218.
10. Pax R, Bennett JL, Fetterer R. 1978. A benzodiazepine derivative and praziquantel: Effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn-Schmiedebergs Arch Pharmacol 304: 309-314.
11. Wolde Mussie E, VandeWaa J, Pax RA, Fetterer R, Bennett JL 1982. Schistosoma mansoni: calcium efflux and effects of calcium-free media on responses of the adult male musculature to praziquantel and other agent-inducing contractions. J Parasitol 68: 48-52.
12. Bricker CS, Depenbusch JW, Bennett JL 1983. Tegumental disruption of S. mansoni caused by praziquantel and Ro 11-3128. Z Parasitenk 69: 61-71.